ReviewJournal of hematology & oncology2013
Ibrutinib and novel BTK inhibitors in clinical development.
Akintunde Akinleye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
105 papers cite itlatest 60 shown
this paperpooled ittrialcites it